The regions spent about 10 billion rubles on the purchase of ineffective medicines.
In Russia, 16.2 billion rubles were spent in 2024 on the purchase of medicines that are not included in the clinical recommendations for the treatment of diseases, the analytical company B3-Med estimated. About 10 billion of these 16 billion rubles are, for example, homeopathic remedies, dietary supplements and phytotherapeutic agents.
For example, for patients with neuroendocrine tumors, regions acquired flowers, leaves, and extracts of birch, St. John's wort, tansy, and milk thistle. For the treatment of nasopharyngeal cancer — calamus, arnica, oak bark, peppermint, fir, chamomile, sage and valerian.
The regions have spent more than 4 billion rubles on medicines for the treatment of rare genetic diseases and about 2 billion rubles on various allergens.
Most of the drugs that are not in the clinical recommendations were purchased in Yakutia, Udmurtia, Chechnya, Karachay-Cherkessia, Dagestan, as well as in the Arkhangelsk and Leningrad regions, Stavropol and Krasnoyarsk territories, as well as in Chukotka.
Evgeny Korovin, the founder of B3-Med and a therapist, stressed that there are currently no strict regulations that restrict the purchase of drugs that are not included in clinical recommendations.
"Such purchases attract attention, because instead of effective therapy, budget funds are spent on medicines that are poorly understood and can harm the patient's health. It is more logical to direct funds to clinical trials of drugs with low proven efficacy or to purchase proven drugs," he said.
According to Evgeny Korovin, the use of herbal medicines or dietary supplements can lead, for example, to liver damage in patients.
Read more in the exclusive Izvestia article:
Medical expenses: regions bought ineffective medicines for 10 billion rubles
Переведено сервисом «Яндекс Переводчик»
